Evidence map›Paper›PMID 41364585›Full record

ArticleMicrobiologyOpen2025

Multi-Resistant Staphylococcus aureus Growth Inhibition Using an Innovative High Voltage Nanosecond Pulser: In Vitro Experimental Results.

Stavros Balasis, Konstantinos Papageorgiou, Sophia Georgiou, Fevronia Kolonitsiou, Nikolaos Giormezis, Antonios Kyriakopoulos, Chrysa Oikonomou, Georgios-Filippos Papageorgiou

Abstract read
In one paragraph

Article in MicrobiologyOpen, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Stavros BalasisDepartment of Orthopedics, University of Patras, Medical School, Patras, Greece.ORCID 0000-0002-3622-5821
Konstantinos PapageorgiouSchool of Engineering, Department of Financial and Management Engineering, University of the Aegean, Chios, Greece.ORCID 0009-0009-6280-1966
Sophia GeorgiouDepartment of Dermatology, University of Patras, Medical School, Patras, Greece.
Fevronia KolonitsiouDepartment of Microbiology, University of Patras, Medical School, Patras, Greece.
Nikolaos GiormezisDepartment of Microbiology, University of Patras, Medical School, Patras, Greece.
Antonios KyriakopoulosPlastic Surgery Department, Evaggelismos Hospital, Athens, Greece.ORCID 0000-0001-8959-7306
Chrysa OikonomouDepartment of Dermatology, University of Patras, Medical School, Patras, Greece.
Georgios-Filippos PapageorgiouFaculty of Medicine, University of Craiova, Craiova, Romania.

Funding

The publication fees of this manuscript have been financed by the Research Council of the University of Patras.
6 · The paper itself

Abstract

Multi-Resistant Bacteria (MRB) is a threatening biomedical problem, whose solution is of paramount importance. Due to the antibiotics resistance there is an emerging need for novel treatment strategies and protocolls. As bacteria tolerance in modern chemotherapeytic agents expands, the introduction of alternative methods is fundamental. The use of High voltage Electric Pulses, through a process known as Irreversible Electroporation (IRE), is an effective alternative bacterial control method. This paper describes a new prototype high voltage nanosecond pulser and validates its effectiveness in the in-vitro growth inhibition of a clinical resistant Staphylococcus aureus strain. Radiofrequency (RF) pulses of 100 ns and 450 ns pulse width and 1 Hz and 1 kHz repetition rate respectively were tested for therapy time in the range of 20-200 s. Increasing the electric field strength up to 11.5 kV/cm and the duration of therapy time up to 200 s results in 3.5 log scale reduction in bacterial cells. Nanosecond electric pulsed fields from our prototype device inhibite S. aureus growth in in-vitro test. It is sugested to test our prototype device in ex-vivo studies and propose a therapeutic protocol for infected skin wounds.

Indexed as

Drug Resistance, Multiple, BacterialElectroporationStaphylococcus aureusAnti-Bacterial AgentsHumansMicrobial Sensitivity TestsStaphylococcal InfectionsAnti-Bacterial Agentselectric field pulserelectroporationnanosecondradiofrequency pulsesstaphylococcus aureus

Identifiers

PMID41364585
PMCPMC12687913

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.